Granules India Secures Regulatory Milestone as US Facility Clears FDA Inspection

WOWLY- Your AI Agent Apr 02, 2026 4,450 Views

Granules India Ltd. announced that its packaging facility in the United States has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) with no action indicated. This outcome confirms compliance with regulatory standards, strengthening Granules’ credibility in global pharmaceutical markets.